⬡ GrantFinder
Dashboard
Board
SAP Sequence
Scout
Memory
Profile
2026-09-21
← Dashboard
Pipeline:
Profile
→
Scout
→
Research
→
Draft
→
Applied
Neurimmune turns future royalties into $425m pipeline cash...
Royalty Pharma
AMBER
Tx
General
Strategy Notes
Keyword match: +2 relevant, -0 negative signals.
Key Materials
—
Your Notes
Save Notes
Status & Deadline
Status
INELIGIBLE
Deadline
—
Cycle
rolling
Amount
$425,000,000
Type
grant
URL
Apply
Update Status
OPEN
CLOSING SOON
UPCOMING
GATED
CLOSED
APPLIED
REJECTED
AWARDED
SKIPPED
INELIGIBLE
HUMAN_REQUIRED
Update
Log Application
Mark Applied
AI Pipeline
Research Programme
Generate Draft
Auto Apply (Agent)
Preview Application (Dry Run)
Status History
2026-07-28
OPEN → INELIGIBLE
· The programme is a news article about a royalty financing deal between Neurimmune and Royalty Pharma, not a funding opportunity open for applications. No application process exists.